Bacterial Biofilm Eradication Agents: A Current Review

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Discovery

Background:

• Bacteria form biofilms, multicellular communities encased in extracellular polymeric substances.
• Biofilms are highly resistant to conventional antibiotic therapy, leading to persistent and recurrent infections.
• Clinically important pathogens like *Pseudomonas aeruginosa*, *Escherichia coli*, and *Staphylococcus aureus* readily form biofilms.

Purpose of the Study:

• To review current understanding of biofilm antibiotic tolerance mechanisms.
• To provide an overview of biofilm remediation strategies.
• To highlight promising biofilm eradication agents and approaches for established biofilms.

Main Methods:

• Literature review of biofilm antibiotic tolerance.
• Analysis of existing biofilm inhibition and dispersal strategies.
• Focus on emerging biofilm eradication agents and therapeutic approaches.

Main Results:

• Established biofilms present a significant challenge due to inherent antibiotic tolerance.
• Current strategies primarily focus on biofilm inhibition or dispersal, not eradication.
• Emerging eradication agents show promise for treating refractory biofilm infections.

Conclusions:

• Developing effective biofilm eradication agents is crucial for treating persistent infections.
• New therapeutic strategies are needed to overcome antibiotic tolerance in established biofilms.
• Promising eradication approaches offer hope for future biofilm therapeutics.